- The Daily Trade
- Posts
- Nvidia's Surge Sparks Optimism: What It Means for Your Stock Picks This Week
Nvidia's Surge Sparks Optimism: What It Means for Your Stock Picks This Week
Ryan Serkes
November 20, 2024
Presented by UpMarket (Sponsor)
Access Hedge Funds and Pre-IPO Deals
Join UpMarket for free and start investing in hedge funds and pre-IPO companies today. No membership fees. No pressure to invest. Start building your diversified portfolio now.
Recent Headlines
Technical Analysis Results
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Hold | ULTOSC Buy | STOCH Buy |
The FDA accepts Aldeyra's resubmitted NDA for topical ocular reproxalap to treat the signs and symptoms of dry eye disease. Stock rises.
Most pharmaceutical businesses are slow-moving by nature due to the lengthy amount of time it takes to develop a new medicine, and AbbVie (NYSE: ABBV) is no exception.In the next five years, expect AbbVie to continue to compete in the disease areas that its pipeline and product mix are currently heavily focused around: immunology, neuroscience, and oncology.It'll also likely continue to compete at a much smaller scale in aesthetics, eye medicines, and a grouping of other areas like infectious disease, but these efforts are ancillary at most.
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Hold | ULTOSC Buy | STOCH Buy |
We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other genomics stocks. Genomics is the study of genes and how they function. Many rapidly growing companies are emerging in the genomics […]
Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund was down 3.72% for the quarter vs. +2.54% for the MSCI ACWI (in $A). It was down 5.59% in September vs. -0.35% for the index. The market rose in the […]
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Hold | ULTOSC Buy | STOCH Buy |
Dow's reversible cross-linking resins provide a unique approach to creating recyclable footwear materials.
DOW is developing new solutions for a circular economy and expanding the REVOLOOP Recycled Plastics Resins line to satisfy customers' sustainability goals.
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Hold | ULTOSC Buy | STOCH Buy |
Unraveling the Financial Fabric and Strategic Directions of Lineage Inc
NOVI, Mich., November 06, 2024--Lineage, Inc. (NASDAQ: LINE) (the "Company"), the world’s largest global temperature-controlled warehouse REIT, today announced its financial results for the third quarter of 2024.
RSI Buy | MFI Buy | WillR Buy | AO Hold |
CCI Buy | BBANDS Buy | ULTOSC Buy | STOCH Buy |
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
WATT's third-quarter 2024 revenues increase 36.1% year over year, driven by higher commercial Power Bridge transmitter system shipments.
RSI Buy | MFI Buy | WillR Buy | AO Hold |
CCI Buy | BBANDS Buy | ULTOSC Buy | STOCH Buy |
Key Insights Using the 2 Stage Free Cash Flow to Equity, Academy Sports and Outdoors fair value estimate is US$70.98...
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Sportsman's Warehouse (NASDAQ:SPWH) and its peers.
We want to hear from YOU!
Your feedback is important to us. We’re always looking for ways to improve and would love to hear your thoughts on how we can make this newsletter even better for you. Whether you have suggestions, ideas, or just want to share what you enjoy most, we’re all ears.
Simply reply to this email with your thoughts. Every comment helps us serve you better.
Thank you for being a valued reader.
How would you rate today's newsletter?If there's anything I can do better, please let me know so I can make improvements! |
Technical Indicator Information
Relative Strength Index (RSI) | Period: 14 days | Overvalued threshold: 70 | Undervalued threshold: 30
Money Flow Index (MFI) | Period: 14 days | Overvalued threshold: 80 | Undervalued threshold: 20
Williams Percent Range (WillR) | Period: 14 days | Overvalued threshold: -20 | Undervalued threshold: -80
Aroon Oscillator (AO) | Period: 14 days | Overvalued threshold: 75 | Undervalued threshold: -75
Moving Average Convergence/Divergence (MACD) | Period: 26/12/9 days | Overvalued threshold: MACD crosses below MACD Signal | Undervalued threshold: MACD crosses above MACD Signal
Stochastic Oscillator (STOCH) | Period: 14/3/3 days | Overvalued threshold: %K crosses below %D above 80 | Undervalued threshold: %K crosses above %D below 20
Commodity Channel Index (CCI) | Period: 20 days | Overvalued threshold: 100 | Undervalued threshold: -100
Bollinger Bands (BBANDS) | Period: 20 days | Overvalued threshold: price >= upper band | Undervalued threshold: price <= lower band
Parabolic Stop and Reverse (SAR) | Period: variable 50 - 100 days | Overvalued threshold: SAR crosses above price | Undervalued threshold: SAR crosses below price
Triple Exponential Average (TRIX) | Period: 15 days | Overvalued threshold: TRIX crosses below 0 | Undervalued threshold: TRIX crosses above 0
Ultimate Oscillator (ULTOSC) | Period: 28/14/7 days | Overvalued threshold: 70 | Undervalued threshold: 30
Directional Movement Index (DMI) | Period: 14 days | Overvalued threshold: PlusDI crosses below MinusDI | Undervalued threshold: PlusDI crosses above MinusDI
Average Directional Index (ADX) | Period: variable 14 days | Requirement: >= 25
Analysis is only performed on securities with market caps in excess of $100 million and with daily trade volume in excess of $50 million.
Disclaimers
The information in our newsletter is not intended to constitute investment advice and is not designed to meet your personal financial situation. It is provided for information purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor or a group of investors. It should not be assumed that any investments in securities, companies, sectors or markets identified and described will be profitable. We strongly advise you to discuss your investment options with your financial advisor prior to making any investments, including whether any investment is suitable for your specific needs.
Although we obtain information contained in our newsletter from sources we believe to be reliable, we cannot guarantee its accuracy. The analysis provided in this newsletter is based on the prior trading day’s closing prices and may not reflect after-hours trading, earnings announcements, or other significant market events that occur outside regular trading hours. As such, any data or commentary may not fully capture the latest market movements or emerging factors. For the most current and comprehensive view, please consider additional sources or consult with a qualified financial professional.
The information provided in our newsletter is private, privileged, and confidential information, licensed for your sole individual use as a subscriber. We reserve all rights to the content of this newsletter. Forwarding, copying, disseminating, or distributing this newsletter in whole or in part, including substantial quotation of any portion the publication or any release of specific investment recommendations, is strictly prohibited.